People with ulcerative colitis may soon have a new medication available to help them, thanks to a global study led by University of Chicago Medicine’s David T. Rubin, MD.
Your privacy is our priority
- Hosted on Secure cloud-based hosting
- SOC II Type 1
- HIPAA compliant
- 2FA authentication
- End-to-end data encryption
- Your health data will not be sold or used without your consent. Ever.
